• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    Cosmos Holdings Shares Q3 2017 Financial Results

    Bryan Mc Govern
    Nov. 28, 2017 09:16AM PST
    Pharmaceutical Investing

    Cosmos Holdings announced its financial results for the third quarter of 2017.

    Cosmos Holdings (OTCQB:COSMD) announced its financial results for the third quarter of 2017.
    As quoted in the press release:

    Highlights:

    • Quarter ended September 30, 2017, versus the quarter ended September 30, 2016, revenue improved 575% to $9.5 million from $1.4 million.
    • Revenue improved sequentially 56%, from $6.1 million in the 2017 second quarter to $9.5 million in the 2017 third quarter.
    • Gross profit increased 434% to $774,813 in the third quarter of 2017 from $144,950 in the third quarter of 2016.
    • Nine-month period ended September 30, 2017, versus the nine-month period ended September 30, 2016, revenue improved 464% to $19.7 million from $3.5 million.
    • Gross profit increased 415% to $1,618,603 in the nine months ended 2017 from $314,332 in the nine months ended 2016.
    • Cosmos expanded its sales network to another four countries; its current network consists of over 110 customers and vendors in 16 different countries.
    • Cosmos continues to diversify customer and vendor base, reducing client concentration risk and fueling the company’s future growth.
    • Cosmos’s clients include some of the largest European wholesalers.

    Click here to read the full press release.

    Source: www.marketwired.com

    pharmaceutical investingfinancial results
    The Conversation (0)

    Go Deeper

    AI Powered

    Aquinox Pharmaceuticals Announces First Quarter 2018 Financial Results

    Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2017

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    Cardiol Therapeutics

    CRDL:CA
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×